Adalimumab group I, line items 1 and 2 and group II line items 1 and 2. Awarded for a base year of 3/9/2024 to 3/8/2025 plus four one year option periods.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79724D0015
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 89% complete
IDV ceiling
$325,063,436.44
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 11 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Organon LLC on March 9, 2024, with a ceiling of $325,063,436.44 for the supply of Adalimumab pen and syringe kits in multiple strengths and configurations.

The contract covers a base year from March 9, 2024, through March 8, 2025, plus four one-year option periods, with ultimate completion on March 8, 2027. Performance supports the VA's Pharmaceutical Prime Vendor program, serving the Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service. The contract encompasses Adalimumab Group I (line items 1 and 2) and Group II (line items 1 and 2).

The originating solicitation, solicitation number 36E79723R0038, sought an uninterrupted supply of Adalimumab kits across four formulations: 40mg/0.4ml pens (estimated annual requirement of 120,089 kits), 40mg/0.4ml syringes (9,715 kits), 40mg/0.8ml pens (149,641 kits), and 40mg/0.8ml syringes (23,595 kits). The primary NAICS code is 325412 (pharmaceutical preparation manufacturing). Contract performance is subject to Executive Order 14398 compliance per modification incorporating FAR clause 52.222-90.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00011 · Modification to incorporate clause 52.222-90, executive order 14398, into the contract. $0
Exercise an Option P00010 · Exercise option year two for adalimumab pen/syringe kits with organon LLC with price changes. $0
Add Subcontract Plan P00009 · Incorporate the 2026 subcontracting plan $0
Other Administrative Action P00008 · 2026 federal ceiling prices $0
Other Administrative Action P00007 · Update authorized negotiator for contract 36E79724D0015. $0
Exercise an Option P00006 · Exercise option year 1 for adalimumab pen/syringe kits. Period of performance 3/9/2025 - 3/8/2026. $0
Other Administrative Action P00005 · POC/authorized negotiator change $0
Add Subcontract Plan P00004 · 2025 subcontracting plan $0
Other Administrative Action P00003 · 2025 public law updates $0
Supplemental Agreement for work within scope P00002 · CRF sales submittal and reporting changes $0
Other Administrative Action P00001 · Point of contact changes $0
Original award $0
Show all 12

Quick answers

Who was awarded contract 36E79724D0015?

36E79724D0015 was awarded to Organon LLC by National Acquisition Center (Headquarters) on March 9, 2024.

How much is contract 36E79724D0015 worth?

36E79724D0015's own ceiling is $325,063,436.

Who can order from contract 36E79724D0015?

36E79724D0015 is a single award indefinite delivery contract.

Was contract 36E79724D0015 competed?

The extent of competition for 36E79724D0015 was full and open competition. The government received 11 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV